Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Interest Expenses (2020 - 2024)

Tenax Therapeutics' Interest Expenses history spans 5 years, with the latest figure at $1507.0 for Q4 2015.

  • On a quarterly basis, Interest Expenses changed N/A to $1507.0 in Q4 2015 year-over-year; TTM through Sep 2016 was $1507.0, a 23.58% decrease, with the full-year FY2024 number at $23000.0, down 4.17% from a year prior.
  • Interest Expenses hit $1507.0 in Q4 2015 for Tenax Therapeutics, up from $571.0 in the prior quarter.
  • Over the last five years, Interest Expenses for TENX hit a ceiling of $5.3 million in Q1 2012 and a floor of -$121881.0 in Q2 2011.
  • Historically, Interest Expenses has averaged $883770.4 across 4 years, with a median of $623252.0 in 2013.
  • Biggest five-year swings in Interest Expenses: surged 36035.82% in 2011 and later plummeted 84.62% in 2013.
  • Tracing TENX's Interest Expenses over 4 years: stood at $871768.0 in 2011, then dropped by 0.49% to $867524.0 in 2012, then decreased by 28.16% to $623252.0 in 2013, then tumbled by 99.76% to $1507.0 in 2015.
  • Business Quant data shows Interest Expenses for TENX at $1507.0 in Q4 2015, $571.0 in Q3 2015, and $1401.0 in Q2 2015.